DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cptnsg/medullary_thyroid) has announced the addition of the "Medullary Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report to their offering.
"Medullary Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Medullary Thyroid Cancer.
A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Medullary Thyroid Cancer.
The report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Medullary Thyroid Cancer. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. The research analysis also presents the global sales forecasts data till 2016.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
For more information visit http://www.researchandmarkets.com/research/cptnsg/medullary_thyroid